Leclercia adecarboxylata is a bacterium that is part of the human microbiota, but can also be found in different environments, such as water, food and animals.Although little associated with disease, some cases of Leclercia adecarboxylata have been reported in hospitals, mainly in newborns admitted to neonatal intensive care units, by parenteral nutrition, which can be isolated from the blood.
Leclercia adecarboxylata infection is most common in immunosuppressed patients, who are those with changes in the immune system, however there are already cases of isolation of this bacteria in people without compromise of the immune system.
- Infection is more common in people with weakened immune systems.
- Such as newborns or people who are hospitalized for a long time.
- For example.
- In addition.
- There is an increased risk of infection in people who undergo parenteral nutrition.
- Use a urinary catheter.
- Have central venous access.
- Or are under mechanical ventilation.
In people with an effective immune system it is often identified with other microorganisms, without receiving proper treatment, however, when the immune system is weakened it is more common for bacteria to be identified separately in the blood, and is critical to proper treatment.Understand how a blood infection is diagnosed.
Treatment of infection by is simple, as this bacteria has shown a high sensitivity to antibiotics, so depending on the clinical condition of the person and the degree of deterioration of the immune system, the doctor may indicate the use of gentamicin, ceftazidim or glycopeptides, such as vancomycin or theicoplanin, for example.
Although most isolates of Leclercia adecarboxylata are sensitive to antibiotics, strains resistant to beta-lactam antibiotics are already being tested because they are able to produce enzymes that prevent the action of these antibiotics, which can make treatment difficult in certain situations.